Jens Kurth, PhD
PARTNER
Experienced biotech and pharma executive with a strong track record in translating scientific innovation into market success, company building, and strategic partnerships across global markets
Key Skills & Expertise
- Global drug development leadership
- Biotech company building & venture fundraising
- Translational strategy & innovation management
- Strategic partnership & alliance management
- Regulatory navigation (FDA/EMA/PMDA/others)
- Global project and collaboration management
Experience
- Co-founded and built multiple biotech companies such as Vivet Therapeutics (Paris), Cimeio Therapeutics (Basel) and Pathogenex (Munich), developing biologics, cell and gene therapies, and raising over €100 million in venture capital funding
- Led strategic business planning, investor relations, licensing transactions and partnerships with major pharmaceutical companies; contributed to the formation of Anokion (Lausanne)
- Novartis, Basel/Tokyo: held senior roles in global biologics and advanced therapies development; led regulatory submissions (IND/BLA) across multiple regions; managed cross-functional teams and external collaborations to drive strategic development programs
- Baxter, Vienna: drove operational excellence initiatives increasing productivity, senior role in CMC leadership for manufacturing process development and optimization, product innovation and regulatory strategy for accelerated product approval
Education
- M.Sc. and Ph.D. in Biochemistry, University of Cologne, Germany (1987 – 1991)
- Postdoctoral Fellow in Neuroscience and Comparative Medicine, Johns Hopkins University, Baltimore, US (1992 – 1997)